| 000 | 01575 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515150840.0 | ||
| 264 | 0 | _c20090710 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1468-3288 | ||
| 024 | 7 |
_a10.1136/gut.2008.150318 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMenchén, L | |
| 245 | 0 | 0 |
_aMatrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand. _h[electronic resource] |
| 260 |
_bGut _cJul 2009 |
||
| 300 |
_a920-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aBlood Platelets _xenzymology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCD40 Ligand _xmetabolism |
| 650 | 0 | 4 |
_aCrohn Disease _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aIntestinal Mucosa _xenzymology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMatrix Metalloproteinase 9 _xphysiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlatelet Activation _xphysiology |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aMarín-Jiménez, I | |
| 700 | 1 | _aArias-Salgado, E G | |
| 700 | 1 | _aFontela, T | |
| 700 | 1 | _aHernández-Sampelayo, P | |
| 700 | 1 | _aRodríguez, M C García | |
| 700 | 1 | _aButta, N V | |
| 773 | 0 |
_tGut _gvol. 58 _gno. 7 _gp. 920-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/gut.2008.150318 _zAvailable from publisher's website |
| 999 |
_c18494562 _d18494562 |
||